Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible
[DOI] [PMC free article] [PubMed] [Google Scholar] 125.McGovern S.F., Hunter K., Holscher C
This is because people with thyroid issues have specific needs, and taking supplements marketed to enhance thyroid health may negatively affect thyroid function, causing their health and symptoms to worsen
This hormone helps lower blood sugar by increasing insulin release, decreasing glucagon, and slowing digestion, which promotes weight loss by curbing appetite
For pharmaceutical executives, the lesson is clear: success in obesity will depend not only on science but also on vigilance, payer alignment, cultural reframing, and equitable access
Weight loss achieved through semaglutide use may indirectly benefit certain digestive conditions associated with obesity, such as gastroesophageal reflux disease (GERD) or metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), but this represents a secondary effect rather than direct gut healing